Covira closes dilutive funding to advance microbiome therapy to prevent postsurgical infections
Oct. 7, 2022
Covira Inc., a spinout from The University of Chicago, has closed its first dilutive funding via an oversubscribed $1.0 million seed round after raising $9.1 million of nondilutive funding.